Literature DB >> 12461260

Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.

Hyo-Cheol Kim1, Ah Young Kim, Joon Koo Han, Jin Wook Chung, Jae Young Lee, Jae Hyung Park, Byung Ihn Choi.   

Abstract

PURPOSE: To evaluate the additional diagnostic value of unenhanced computed tomographic (CT) images in the depiction of viable tumor in patients who were treated with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) and followed up with biphasic helical CT that included the acquisition of unenhanced images.
MATERIALS AND METHODS: We performed helical CT (with unenhanced, arterial, and portal phases) in 54 patients who had been treated with TACE for HCC. Image analysis was first performed with only those images obtained in the arterial and portal venous phases of helical CT. A second analysis was then performed with unenhanced images, arterial images, and portal venous images that focused on the additional value of unenhanced images. The value of additional unenhanced images was evaluated by means of interobserver agreement (kappa statistic) and receiver operating characteristic (ROC) analysis.
RESULTS: The two readers detected 128 and 129 lesions. Unenhanced images were valuable for 32 of 129 lesions (23 patients) for reader 1 and for 29 of 128 lesions (21 patients) for reader 2. Although there was no significant difference between biphasic CT alone and biphasic CT with unenhanced images, results of ROC analysis showed higher diagnostic performance with biphasic CT with unenhanced images than with biphasic CT alone for detecting viable tumor.
CONCLUSION: The study data demonstrate the diagnostic value of unenhanced images interpreted in conjunction with biphasic CT images for follow-up of patients who have previously been treated with TACE for HCC.

Entities:  

Mesh:

Year:  2002        PMID: 12461260     DOI: 10.1148/radiol.2253011346

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Imaging appearance of treated hepatocellular carcinoma.

Authors:  Francesco Agnello; Giuseppe Salvaggio; Giuseppe Cabibbo; Marcello Maida; Roberto Lagalla; Massimo Midiri; Giuseppe Brancatelli
Journal:  World J Hepatol       Date:  2013-08-27

2.  Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization.

Authors:  Eu Hyun Kim; Jung Suk Oh; Ho Jong Chun; Byung Gil Choi; Hae Giu Lee
Journal:  Diagn Interv Radiol       Date:  2018-09       Impact factor: 2.630

3.  Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.

Authors:  Seung Joon Choi; Jonghoon Kim; Jongbum Seo; Hyung Sik Kim; Jong-min Lee; Hyunjin Park
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

4.  Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).

Authors:  Stephan Zangos; Katrin Eichler; Jörn O Balzer; Ralf Straub; Renate Hammerstingl; Christopher Herzog; Thomas Lehnert; Mathias Heller; Axel Thalhammer; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-08-08       Impact factor: 5.315

5.  Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation.

Authors:  Sue Jin Kim; Moon Seok Choi; Ja Young Kang; Dong Il Choi; Cheol Keun Park; Geum Youn Gwak; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

6.  Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

7.  Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.

Authors:  Zhen Li; Dao-Yu Hu; Qian Chu; Jian-Hong Wu; Chun Gao; Yu-Qing Zhang; Yan-Rong Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Characteristics of liver on magnetic resonance diffusion-weighted imaging: dynamic and image pathological investigation in rabbit liver VX-2 tumor model.

Authors:  You-Hong Yuan; En-Hua Xiao; Jian-Bin Liu; Zhong He; Ke Jin; Cong Ma; Jun Xiang; Jian-Hua Xiao; Wei-Jian Chen
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

9.  Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.

Authors:  Jun-Gong Zhao; Gan-Sheng Feng; Xiang-Quan Kong; Xin Li; Ming-Hua Li; Ying-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

10.  Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.

Authors:  Qi-Yu Liu; Chuan-Dong He; Ying Zhou; Dan Huang; Hua Lin; Zhong Wang; Dong Wang; Jin-Qiu Wang; Li-Ping Liao
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.